• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Momenta Pharmaceuticals Inc. (MNTA)

    -NasdaqGS
    17.57 Up 0.49(2.87%) Apr 17, 4:00PM EDT
    |After Hours : 17.70 Up 0.13 (0.74%) Apr 17, 7:00PM EDT
    Add to Portfolio
    Prev Close:17.08
    Open:17.46
    Bid:17.24 x 1000
    Ask:18.34 x 100
    1y Target Est:15.06
    Beta:1.85
    Next Earnings Date: 1-May-15MNTA Earnings announcement
    Day's Range:17.30 - 18.48
    52wk Range:9.38 - 20.43
    Volume:1,985,055
    Avg Vol (3m):887,834
    Market Cap:936.69M
    P/E (ttm):N/A
    EPS (ttm):-1.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MNTA

    Comparison

    Symbol% ChgMkt Cap
    MNTAUp 2.87%936.69M
    GSKDown 0.61%113.76B
    SNYDown 0.88%135.14B
    TEVAUp 2.24%55.29B

    Key Statistics

    Forward P/E (1 yr):67.58
    P/S (ttm):17.43
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.88
    Quarterly EPS Est (Mar-15) :-0.45
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on developing generic versions of complex drugs, biosimilars, and novel therapeutics for oncology and autoimmune diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback